Loading...
Loading...
Among the 4 tracked institutional investors we monitor, CNTB (CONNECT BIOPHARMA HLDGS LTD) is held with a combined value of $1.91M across 727,741 shares. The largest holder is MILLENNIUM MANAGEMENT LLC with a position worth $1.24M (0.00% of their portfolio). 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$1.91M
Total Shares Held
727,741
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | $1.24M | 0.00% | +908.7% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $316.23K | 0.00% | -15.7% |
| 3 | CITADEL ADVISORS LLC | $295.21K | 0.00% | +13.2% |
| 4 | Point72 Asset Management, L.P. | $51.79K | 0.00% | +19.8% |
As of the latest SEC 13F filings, MILLENNIUM MANAGEMENT LLC is the largest institutional holder of CNTB with a position worth $1.24M, representing 0.00% of their portfolio. In total, 4 institutional investors hold CNTB with a combined value of $1.91M.
Institutional investors hold $1.91M worth of CNTB stock across 4 positions. The largest institutional holder is MILLENNIUM MANAGEMENT LLC with $1.24M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CNTB, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CNTB positions.